Skip to main content

Want a detailed portfolio tracker?

PMGC (ELAB) P/E (2023 - 2026)

PMGC (ELAB) P/E from Nov 21, 2023 to Jun 3, 2026. The TTM PMGC (ELAB) P/E is -0.03. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of PMGC (ELAB)

YearP/EChange
2026-0.03-94.90%
2025-0.61-98.47%
2024-39.59-5.12%
2023-41.73N/A

Comparison PMGC (ELAB) P/E with competitors

PMGC (ELAB) P/E is -0.03.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-105.50%
NBYStablecoin Development Corp0.10-430.55%
ENLVEnlivex Therapeutics Ltd0.15-585.70%
FGENFibroGen Inc0.24-876.19%
TRAWTraws Pharma Inc0.47-1628.89%
FBIOFortress Biotech Inc0.71-2382.98%
CHRSCoherus Biosciences Inc0.98-3262.87%
ORMPOramed Pharmaceuticals Inc1.47-4864.51%
AGENAgenus Inc2.05-6723.88%
VIVSVivoSim Labs Inc2.54-8299.66%
INVAInnoviva Inc3.19-10410.28%
CRMDCorMedix Inc3.65-11888.72%
ABEOAbeona Therapeutics Inc4.20-13697.32%
VXRTVaxart Inc4.26-13880.35%
CVACCureVac N.V.4.45-14475.35%
SRPTSarepta Therapeutics Inc4.62-15052.88%
GLPGGalapagos NV4.86-15811.51%
RIGLRigel Pharmaceuticals4.92-16007.79%
ZVRAZevra Therapeutics Inc4.97-16184.03%
ABUSArbutus Biopharma Corp5.69-18511.31%
CGENCompugen Ltd7.38-23976.89%
AUPHAurinia Pharmaceuticals Inc9.25-30015.79%
ACADAcadia Pharmaceuticals Inc9.59-31104.25%
OMEROmeros Corporation9.88-32059.48%
PLXProtalix BioTherapeutics Inc9.91-32142.59%
SPROSpero Therapeutics Inc10.73-34812.32%
ADMAAdma Biologics Inc11.33-36739.27%
SVASinovac Biotech Ltd11.44-37080.10%
TBPHTheravance Biopharma Inc11.78-38181.50%
HRMYHarmony Biosciences Holdings Inc12.18-39487.26%
TGTXTG Therapeutics Inc13.18-42717.71%
INCYIncyte Corp13.38-43372.86%
SABSSAB Biotherapeutics Inc14.06-45557.86%
XOMAXOMA Corp14.95-48427.75%
REGNRegeneron Pharmaceuticals Inc14.98-48540.93%
PBYIPuma Biotechnology Inc15.05-48767.94%
EXELExelixis Inc15.79-51175.09%
NAGENiagen Bioscience Inc16.35-52986.28%
CPRXCatalyst Pharmaceuticals Inc17.34-56186.98%
MDXGMimedx Group Inc17.38-56285.93%
ARGXArgen X SE23.07-74705.65%
HALOHalozyme Therapeutics Inc23.20-75122.80%
XOMAOXOMA Corp25.34-82056.46%
VRTXVertex Pharmaceuticals Inc25.66-83062.14%
XOMAPXOMA Corp25.67-83108.38%
CTMXCytomX Therapeutics Inc25.70-83198.28%
ASNDAscendis Pharma A/S26.35-85320.22%
RPRXRoyalty Pharma plc - Class A27.50-89010.83%
SLNOSoleno Therapeutics Inc29.02-93925.71%
LGNDLigand Pharmaceuticals Inc - Class B30.19-97713.00%
BMRNBiomarin Pharmaceutical Inc37.51-121385.84%
APLSApellis Pharmaceuticals Inc39.02-126281.32%
KRYSKrystal Biotech Inc39.70-128468.58%
GMABGenmab40.20-130104.83%
ONCBeiGene Ltd67.03-216842.62%
TECHBio-Techne Corp68.59-221913.36%
VCELVericel Corp80.63-260827.85%
PHARPharming Group N.V.87.74-283822.27%
ALNYAlnylam Pharmaceuticals Inc124.93-404093.70%
TLXTelix Pharmaceuticals Ltd139.89-452459.61%
CORTCorcept Therapeutics Inc158.39-512277.94%